Alterola Biotech Stock Probability of Future Pink Sheet Price Finishing Under 0.007929
| ABTI Stock | USD 0.01 0 32.76% |
Alterola |
Alterola Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alterola Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alterola Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alterola Biotech is way too risky over 90 days horizon | |
| Alterola Biotech has some characteristics of a very speculative penny stock | |
| Alterola Biotech appears to be risky and price may revert if volatility continues | |
| Alterola Biotech has high likelihood to experience some financial distress in the next 2 years | |
| Alterola Biotech currently holds 251.18 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Alterola Biotech has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Alterola Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Alterola Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alterola Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alterola to invest in growth at high rates of return. When we think about Alterola Biotech's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.47 M) with profit before overhead, payroll, taxes, and interest of 0. |
Alterola Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alterola Pink Sheet often depends not only on the future outlook of the current and potential Alterola Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alterola Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 770 M | |
| Shares Float | 163.6 M |
Alterola Biotech Technical Analysis
Alterola Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Alterola Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Alterola Biotech. In general, you should focus on analyzing Alterola Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Alterola Biotech Predictive Forecast Models
Alterola Biotech's time-series forecasting models is one of many Alterola Biotech's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Alterola Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Alterola Biotech
Checking the ongoing alerts about Alterola Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Alterola Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Alterola Biotech is way too risky over 90 days horizon | |
| Alterola Biotech has some characteristics of a very speculative penny stock | |
| Alterola Biotech appears to be risky and price may revert if volatility continues | |
| Alterola Biotech has high likelihood to experience some financial distress in the next 2 years | |
| Alterola Biotech currently holds 251.18 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Alterola Biotech has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Alterola Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Alterola Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alterola Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alterola to invest in growth at high rates of return. When we think about Alterola Biotech's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.47 M) with profit before overhead, payroll, taxes, and interest of 0. |
Other Information on Investing in Alterola Pink Sheet
Alterola Biotech financial ratios help investors to determine whether Alterola Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterola with respect to the benefits of owning Alterola Biotech security.